This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Wyeth. Active years: 2010-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2014
Title: The Innovations of Jay Marshall Feingold
Introduction
Jay Marshall Feingold is a distinguished inventor based in Wynnewood, Pennsylvania, known for his significant contributions to the field of oncology. With three patents to his name, Feingold is at the forefront of innovative cancer treatment solutions that have the potential to impact patient care dramatically.
Latest Patents
Feingold’s latest patents represent groundbreaking advancements in cancer treatment methodologies. One of his notable inventions focuses on the anti-tumor activity of CCI-779 in treating papillary renal cell carcinoma. This patent outlines a method for the effective use of CCI-779, offering new hope for patients battling this challenging form of cancer.
Another significant patent introduced by Feingold pertains to establishing a cut-point in PTEN protein expression that reliably identifies tumors and predicts their response to pan-ErbB inhibitors. This innovative approach measures PTEN protein expression quantitatively, identifying tumors with inactivated alleles of the PTEN gene. The patients with a normalized PTEN score of PTEN null would benefit from treatment with a pan-ErbB tyrosine kinase inhibitor, enhancing personalized cancer treatment strategies.
Career Highlights
Currently, Jay Marshall Feingold is employed at Wyeth, a company renowned for its commitment to pharmaceutical innovation and research. Through his role at Wyeth, Feingold has been pivotal in developing treatments that seek to improve the quality of life for cancer patients.
Collaborations
Throughout his career, Feingold has collaborated with talented professionals in the field, including his coworkers Anna Berkenblit and Christina Marie Coughlin. These collaborations have facilitated the exchange of ideas, leading to the successful development of impactful patents.
Conclusion
In summary, Jay Marshall Feingold stands out as a prominent inventor whose work has played a vital role in advancing cancer treatment. His innovative patents not only reflect his dedication to medical science but also underline the importance of collaboration in achieving significant breakthroughs in healthcare. As he continues his work at Wyeth, the potential for further contributions in the field of oncology remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile